Illumina(US:ILMN) ZACKS·2025-05-05 14:21Core Insights - Analysts forecast Illumina (ILMN) to report quarterly earnings of $0.96 per share, reflecting a year-over-year increase of 966.7% [1] - Expected revenues are projected at $1.04 billion, indicating a decline of 3.5% compared to the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has been revised downward by 0.6% in the past 30 days [2] - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock [3] Revenue Breakdown - Analysts expect 'Revenue- Product revenue- Consumable' to be $763.09 million, showing a year-over-year change of +0.1% [5] - The estimate for 'Revenue- Service and other revenue' is $170.12 million, suggesting a decline of 14.9% year over year [5] - 'Revenue- Product revenue' is predicted to reach $872.04 million, indicating a decrease of 0.5% [5] Core Revenue Metrics - 'Revenues- Core Illumina- Service and other revenue' is expected to be $175.08 million, reflecting a year-over-year increase of 1.2% [6] - 'Revenues- Core Illumina- Total product revenue' is projected at $869.69 million, suggesting a decline of 1.5% year over year [6] Instrument and Consumable Revenue - 'Revenue- Product revenue- Instruments' is likely to be $108.95 million, indicating a change of -4.4% from the prior-year quarter [7] - 'Revenues- Core Illumina- Consumables' is expected to reach $748.87 million, reflecting a decrease of 2.6% [7] Sequencing Revenue Estimates - 'Revenue- Sequencing- Instruments' is projected at $108.51 million, indicating a change of -1.4% from the year-ago quarter [8] - 'Revenue- Sequencing- Consumables' is expected to be $679.85 million, suggesting a decline of 2.6% year over year [8] Microarrays Revenue Forecast - 'Revenue- Microarrays- Instruments' is estimated to reach $3.61 million, indicating a change of -9.9% from the prior-year quarter [9] - 'Revenue- Microarrays- Consumables' is projected at $74.59 million, reflecting a year-over-year change of +5.1% [9] - Overall, 'Revenue- Core Illumina' is expected to be $1.03 billion, indicating a decline of 2.1% year over year [9] Stock Performance - Illumina shares have returned +5% over the past month, outperforming the Zacks S&P 500 composite's +0.4% change [9] - With a Zacks Rank 3 (Hold), ILMN is expected to mirror the overall market performance in the near future [10]